Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
NEVRO CORP reported preliminary financial results for fourth quarter and full year ended December 31, 2023.
- Period
- fourth quarter and full year ended December 31, 2023
- Result
- preliminary results
Exact text from the filing
On January 9, 2024, Nevro Corp. ("Nevro" or the "Company") issued a press release announcing its preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2023.
View on SEC.gov
Restructurings & Charges
SEC 8-K Item 2.05/2.06
confidence 0.9
NEVRO CORP announced a restructuring with charges of $5 million to $6 million restructuring charge affecting corporate, sales and marketing, and operations positions but largely focused on internally facing roles (63 employees, which represented approximately 5% of the Company’s total number of employees).
- Type
- restructuring
- Charge
- $5 million to $6 million restructuring charge
- Affected area
- corporate, sales and marketing, and operations positions but largely focused on internally facing roles
- Headcount
- 63 employees, which represented approximately 5% of the Company’s total number of employees
Exact text from the filing
expense increases, including inflation, merit increases and other acquisition-related expenses. In addition, GAAP operating expenses in the first quarter of 2024 will reflect a $5 million to $6 million restructuring charge, consisting of one-time severance and other termination benefit costs. The Company expects that the Restructuring, including related cash
View on SEC.gov